ORMP
Oramed Pharmaceuticals Inc
Price:  
2.32 
USD
Volume:  
91,048.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ORMP EV/EBITDA

-429.3%
Upside

As of 2024-05-24, the EV/EBITDA ratio of Oramed Pharmaceuticals Inc (ORMP) is -8.73. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ORMP's latest enterprise value is 135.96 mil USD. ORMP's TTM EBITDA according to its financial statements is -15.58 mil USD. Dividing these 2 quantities gives us the above ORMP EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 10.1x - 17.9x 14.1x
Forward P/E multiples 18.5x - 20.6x 20.2x
Fair Price (8.16) - (7.93) (7.64)
Upside -451.6% - -441.6% -429.3%
2.32 USD
Stock Price
(7.64) USD
Fair Price

ORMP EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-23 -8.73
2024-05-22 -8.67
2024-05-21 -8.70
2024-05-20 -8.86
2024-05-17 -8.67
2024-05-16 -8.75
2024-05-15 -8.91
2024-05-14 -9.12
2024-05-13 -8.96
2024-05-10 -8.92
2024-05-09 -8.88
2024-05-08 -9.01
2024-05-07 -8.93
2024-05-06 -9.17
2024-05-03 -8.80
2024-05-02 -8.78
2024-05-01 -8.78
2024-04-30 -8.73
2024-04-29 -9.03
2024-04-26 -9.09
2024-04-25 -8.67
2024-04-24 -8.86
2024-04-23 -8.80
2024-04-22 -8.75
2024-04-19 -8.60
2024-04-18 -8.41
2024-04-17 -8.75
2024-04-16 -8.93
2024-04-15 -8.99
2024-04-12 -9.25
2024-04-11 -9.40
2024-04-10 -9.61
2024-04-09 -9.69
2024-04-08 -9.90
2024-04-05 -9.48
2024-04-04 -9.48
2024-04-03 -9.84
2024-04-02 -9.97
2024-04-01 -10.05
2024-03-28 -10.29
2024-03-27 -10.03
2024-03-26 -9.77
2024-03-25 -9.87
2024-03-22 -10.26
2024-03-21 -9.97
2024-03-20 -10.39
2024-03-19 -10.05
2024-03-18 -10.00
2024-03-15 -10.29
2024-03-14 -9.66